SCHEMBL5655779

SCHEMBL5655779

COc1ccccc1N(CCBr)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 3/20 0.42
HTT P42858 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 1/20 0.41
SNCA P37840 1/20 0.40
TSPO P30536 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ESR1 P03372 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
PTGIR P43119 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11472981 0.86 LPAR1 (0.44) SMN1; SMN2POLBALDH1A1HTTLMNA
SCHEMBL5657807 0.85 GLA (0.47) SMN1; SMN2ALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL5656279 0.84 L3MBTL1 (0.47) SMN1; SMN2POLBALDH1A1HTTLMNA
SCHEMBL10941845 0.82 ESR1 (0.49) SMN1; SMN2POLBALDH1A1HTTTSHR
SCHEMBL11808509 0.76 CA1 (0.44) ALDH1A1HTTTSHRL3MBTL1ESR1
SCHEMBL1334670 0.76 POLB (0.50) SMN1; SMN2POLBALDH1A1HTTALOX15
SCHEMBL5656387 0.76 HTR1A (0.61) ALDH1A1TSHRKMT2AMEN1
Bromide SCHEMBL11808501 0.75 CA1 (0.43) ALDH1A1HTTTSHRL3MBTL1ESR1
SCHEMBL4601280 0.74 PAX8 (0.50) SMN1; SMN2POLBHTTTSHRLMNA
SCHEMBL7746650 0.74 SMN1; SMN2 (0.49) SMN1; SMN2POLBALDH1A1HTTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C SMN1; SMN2 3970/4885POLB 3764/4885ALDH1A1 1018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.